Air Pollution Exposure Tied to Greater ALS Risk in Women in Study
Higher long-term exposure to certain forms of air pollution — specifically coarse particulate matter, such as that from traffic pollutants…
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Higher long-term exposure to certain forms of air pollution — specifically coarse particulate matter, such as that from traffic pollutants…
Deep machine-learning models using neural networks — computer algorithms inspired in the biological networks of the human brain —may help…
Starting treatment with riluzole earlier in the disease course could prolong overall survival for people with amyotrophic lateral sclerosis…
The U.S. Food and Drug Administration (FDA) is funding several novel research projects related to amyotrophic lateral sclerosis (ALS)…
A cholesterol-related protein, called apolipoprotein A1 (ApoA1), can prevent the death of endothelial cells — those lining blood vessel walls…
The nonprofit EverythingALS is teaming up with several biotech companies for a study into the feasibility of monitoring amyotrophic…
Helixmith has unveiled its new multi-approach program called DART — Defeating ALS through Regenerative Therapeutics — to develop new…
There is no compelling evidence to suggest any medication increases the risk of developing amyotrophic lateral sclerosis (ALS), according…
Early treatment with Biogen’s experimental therapy tofersen slows disease progression in people with amyotrophic lateral sclerosis (ALS)…
PrimeC, an experimental combination treatment for amyotrophic lateral sclerosis (ALS) being developed by NeuroSense Therapeutics, was well tolerated…